K. Inoue

发表

[Usefulness of contact thermography for the evaluation of chemotherapeutic effectiveness in breast cancer].

T. Kurihara, Y. Higashi, K. Suemasu, 1993, Gan to kagaku ryoho. Cancer & chemotherapy.

Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

A. El‐Naggar, C. Dinney, I. Fidler, 2001, The American journal of pathology.

Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.

A. Scott, M. Brechbiel, K. Inoue, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is frozen section effective for diagnosis of unsuspected gallbladder cancer during laparoscopic cholecystectomy?

K. Inoue, T. Aoki, Y. Koyanagi, 2001, Surgical Endoscopy And Other Interventional Techniques.

A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy.

M. Tsuboi, K. Inoue, Y. Tokuda, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer

K. Inoue, T. Tani, Hiroshi Yamamoto, 2013, Gastric Cancer.

Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.

K. Inoue, H. Imamura, T. Tsujinaka, 2012, European Journal of Surgical Oncology.

Alpelisib Plus Fulvestrant for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Advanced Breast Cancer: Final Overall Survival Results From SOLAR-1.

H. Rugo, H. Iwata, D. Juric, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Mutation and expression of the DCC gene in human lung cancer.

J. Yokota, T. Kohno, K. Inoue, 2000, Neoplasia.

Overexpression of c-Met/hepatocyte growth factor receptors in human prostatic adenocarcinoma.

K. Inoue, T. Shuin, M. Furihata, 1998, Acta medica Okayama.

Diagnostic value of bone‐turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma

K. Inoue, Y. Nakanishi, N. Hara, 2001, Cancer.

[Hypercalcemia in breast cancer].

K. Inoue, N. Horikoshi, H. Nakada, 1984, Gan to kagaku ryoho. Cancer & chemotherapy.

Polychlorinated biphenyls promote 1-nitropyrene-induced lung tumorigenesis without the induction of K-ras gene mutation in A/J mice.

K. Inoue, Y. Nakanishi, N. Hara, 2001, Teratogenesis, carcinogenesis, and mutagenesis.

High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.

K. Inoue, M. Furihata, Y. Ohtsuki, 1993, Cancer research.

Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients.

M. Kurosumi, Y. Higashi, K. Suemasu, 2000, Oncology reports.

[Preclinical evaluation of a new camptothecin derivative, CPT-11, on the subrenal capsule assay].

H. Shibata, K. Inoue, S. Chen, 1987, Gan to kagaku ryoho. Cancer & chemotherapy.

Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis

K. Inoue, S. Abe, Y. Kawakami, 2004, Virchows Archiv.

Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer

K. Inoue, S. Abe, Y. Kawakami, 1994, Cancer.

Antitumor activities of seventeen alkylating agents against human mammary carcinoma (MS-1) in nude mice.

K. Inoue, S. Fujimoto, M. Ogawa, 1981, Nagoya journal of medical science.

[Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].

K. Inoue, A. Hirano, K. Shinagawa, 1989, Gan to kagaku ryoho. Cancer & chemotherapy.

Corrigendum to: Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines Leukemia Research 24 (2000), 255-262.

J. Yokota, T. Kohno, Y. Hayashi, 2001, Leukemia research.

Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.

C. Dinney, D. Hicklin, K. Inoue, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Metastatic squamous-cell carcinomas derived from solar keratosis.

K. Inoue, H. Fukamizu, K. Matsumoto, 1985, The Journal of dermatologic surgery and oncology.

[A case study of alpha feto protein (AFP)-producing gastric carcinoma with multiple liver metastases, in which chemotherapy was effective enough to once save a life in rapid decline].

K. Inoue, M. Tadokoro, Y. Watanabe, 2000, Gan to kagaku ryoho. Cancer & chemotherapy.

Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.

Y. Furuta, S. Fukuda, K. Inoue, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non‐small cell lung cancer

K. Inoue, Y. Kawakami, H. Miyamoto, 1990, Cancer.

Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.

K. Inoue, S. Fujimoto, M. Ogawa, 1985, Japanese journal of cancer research : Gann.

Estrogen induces different responses in dermal and lung fibroblasts: special reference to collagen.

K. Inoue, M. Hosokawa, T. Takeda, 1981, Connective tissue research.

[Correlation between antitumor effects against human mammary carcinoma (MX-1) in nude mice and clinical efficacy of human breast cancer in thirty-four antitumor agents].

K. Inoue, S. Fujimoto, M. Ogawa, 1983, Nihon Gan Chiryo Gakkai shi.

Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.

K. Inoue, S. Fujimoto, M. Ogawa, 1980, Gan.

Site-specific hypomethylation of the c-myc oncogene in human hepatocellular carcinoma.

K. Inoue, S. Nambu, H. Saski, 1987, Japanese journal of cancer research : Gann.

Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.

C. Dinney, D. Hicklin, K. Inoue, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

C. Dinney, K. Inoue, M. Bar‐eli, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.

C. Dinney, K. Inoue, M. Bar‐eli, 2000, Cancer research.

Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.

C. Dinney, I. Fidler, K. Inoue, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.

C. Wood, C. Dinney, K. Inoue, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Second-line chemotherapy with weekly cisplatin and irinotecan in patients with refractory lung cancer.

K. Inoue, Y. Nakanishi, N. Hara, 1999, American journal of clinical oncology.

The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.

R. Millikan, C. Dinney, K. Inoue, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.

C. Dinney, D. Hicklin, K. Inoue, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.

K. Inoue, Y. Nakanishi, N. Hara, 2000, Cancer research.

Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8.

C. Wood, C. Dinney, K. Inoue, 2001, Oncology reports.

Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21.

K. Inoue, Y. Nakanishi, N. Hara, 2000, American journal of respiratory cell and molecular biology.

Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.

C. Dinney, I. Fidler, K. Inoue, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial

K. Inoue, N. Masuda, S. Morita, 2018, Breast Cancer.

Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.

C. Dinney, K. Inoue, T. Shuin, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical study of aclacinomycin A.

H. Ueoka, K. Inoue, N. Horikoshi, 1979, Cancer treatment reports.

[Effect of intra-arterial infusion of adriamycin on locally advanced primary breast cancer--second report].

K. Inoue, H. Koyama, Y. Takatsuka, 1983, Gan to kagaku ryoho. Cancer & chemotherapy.

[Multihospital randomized study on the adjuvant chemotherapy with mitomycin-C and Futraful for gastric cancer V. Estimation of 5-year survival rate].

K. Inoue, T. Taguchi, O. Abe, 1982, Gan to kagaku ryoho. Cancer & chemotherapy.

[High-dose cyclophosphamide, thio-TEPA, etoposide with autologous bone marrow transplantation for refractory cancers].

K. Inoue, A. Hirano, N. Horikoshi, 1990, Gan to kagaku ryoho. Cancer & chemotherapy.

Evaluation of prognostic factors for 233 patients with recurrent advanced breast cancer.

K. Inoue, A. Hirano, K. Aiba, 1991, Japanese journal of clinical oncology.

[Clinical evaluation of adriamycin in advanced and recurrent breast cancer (No. 4)--Joint study by 30 institutes on the duration of remission using various maintenance therapies in patients treated with CAF. Clinical Study Group of Adriamycin for Breast Cancer in Japan].

K. Inoue, O. Abe, H. Koyama, 1988, Gan to kagaku ryoho. Cancer & chemotherapy.

[Human tumor stem cell assay].

K. Inoue, M. Arakawa, M. Ogawa, 1982, Gan to kagaku ryoho. Cancer & chemotherapy.

Relationship between existence of lymphatic invasion in peritumoral breast tissue and presence of axillary lymph node metastasis in invasive ductal carcinoma of the breast.

M. Kurosumi, Y. Higashi, K. Suemasu, 2001, Oncology reports.

[A randomized trial comparing ACF (adriamycin, cyclophosphamide, ftorafur) and ACF/MVMF (mitomycin C, vincristine, methotrexate, ftorafur)--a non-cross-resistant alternating chemotherapy of recurrent and advanced breast cancer].

K. Inoue, T. Nakamura, Y. Ito, 1989, Gan to kagaku ryoho. Cancer & chemotherapy.

Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines.

J. Yokota, T. Kohno, Y. Hayashi, 2000, Leukemia research.

[Arterial infusion of combination chemotherapy consisting of adriamycin and mitomycin C for liver metastases of breast cancer].

K. Inoue, T. Nakamura, Y. Ito, 1986, Gan to kagaku ryoho. Cancer & chemotherapy.

Ki-67 labeling indices in non-small cell lung cancer: comparison between image cytometry and flow cytometry.

K. Inoue, H. Dosaka-akita, Y. Kawakami, 1997, Cytometry.

[Clinical effects of human fibroblast interferon on malignant tumors].

K. Inoue, K. Ezaki, K. Aiba, 1982, Gan to kagaku ryoho. Cancer & chemotherapy.

[In vitro evaluation of anticancer drugs and retrospective clinical trials with the human tumor cloning system].

K. Inoue, N. Horikoshi, M. Ogawa, 1985, Nihon Gan Chiryo Gakkai shi.

Activation of two Cynops genes, fork head and sonic hedgehog, in animal cap explants.

K. Inoue, M. Ogawa, K. Takeshima, 1996, Biochemical and biophysical research communications.

[A phase I study of carboplatin].

K. Inoue, Y. Kuraishi, K. Aiba, 1987, Gan to kagaku ryoho. Cancer & chemotherapy.

[Breast cancer and hematological malignancy in the same patients].

K. Inoue, F. Kasumi, N. Horikoshi, 1985, Gan no rinsho. Japan journal of cancer clinics.

[Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].

K. Inoue, K. Ezaki, N. Horikoshi, 1983, Gan to kagaku ryoho. Cancer & chemotherapy.

P347 Benefit of denosumab therapy in patients with bone metastases from breast cancer: A number-needed-to-treat (NNT) analysis

K. Inoue, A. Stopeck, G. Steger, 2011 .

[Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].

K. Inoue, T. Taguchi, O. Abe, 1989, Gan to kagaku ryoho. Cancer & chemotherapy.

Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non‐small cell lung cancer

K. Inoue, Y. Kawakami, H. Miyamoto, 1990, Cancer.

[Case report of meningeal carcinomatosis of gastric cancer successfully treated with intrathecal and systemic chemotherapy].

K. Inoue, Y. Takano, N. Horikoshi, 1985, Gan to kagaku ryoho. Cancer & chemotherapy.

[5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].

K. Inoue, K. Fujiwara, I. Kono, 1986, Gan to kagaku ryoho. Cancer & chemotherapy.

[Hepatic artery embolization using balloon catheters].

K. Inoue, H. Nakamura, H. Oi, 1985, Rinsho hoshasen. Clinical radiography.

Phase III trial comparing 4-cycle doxorubicin plus cyclophosphamide followed by 4-cycle taxan with 8-cycle taxan as adjuvant therapy for node-positive breast cancer: Results of N-SAS-BC02 trial.

H. Iwata, H. Mukai, Y. Ohashi, 2016, Journal of Clinical Oncology.